Collegium Pharma (COLL) Tops Q4 EPS by 3c

Collegium Pharma (NASDAQ: COLL) reported Q4 EPS of ($0.54), $0.03 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $10.8 million versus the consensus estimate of $9.88 million.

For earnings history and earnings-related data on Collegium Pharma (COLL) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance